If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuseppe Capri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Paclitaxel Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Appointments and Schedules Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

  • 2414 Citations
  • 23 h-Index
  • 45 Article
  • 1 Review article
5 Citations (Scopus)

Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives

Vernieri, C., Milano, M., Brambilla, M., Mennitto, A., Maggi, C., Cona, M. S., Prisciandaro, M., Fabbroni, C., Celio, L., Mariani, G., Bianchi, G. V., Capri, G. & de Braud, F., Jul 2019, In : Critical Reviews in Oncology/Hematology. 139, p. 53-66 14 p.

Research output: Contribution to journalReview article

Therapeutic Human Experimentation
Breast Neoplasms
Standard of Care
Treatment Failure
Pharmaceutical Preparations
1 Citation (Scopus)

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Vernieri, C., Prisciandaro, M., Milano, M., Cona, M. S., Maggi, C., Brambilla, M., Mennitto, A., Fabbroni, C., Farè, E., Cresta, S., Celio, L., Mariani, G., Bianchi, G., Capri, G. & de Braud, F., Apr 2019, In : Clinical Breast Cancer. 19, 2, p. e306-e318

Research output: Contribution to journalArticle

gemcitabine
Carboplatin
Breast Neoplasms
Safety
Disease-Free Survival

Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study

Mariani, G., Galli, G., Cavalieri, S., Valagussa, P., Bianchi, G. V., Capri, G., Cresta, S., Ferrari, L., Damian, S., Duca, M., de Braud, F. & Moliterni, A., Mar 1 2019, In : Breast Journal. 25, 2, p. 237-242 6 p.

Research output: Contribution to journalArticle

Anthracyclines
Breast Neoplasms
Drug Therapy
Paclitaxel
Methotrexate

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer

Vernieri, C., Mennitto, A., Prisciandaro, M., Huber, V., Milano, M., Rinaldi, L., Cona, M. S., Maggi, C., Ferrari, B., Manoukian, S., Mariani, G., Bianchi, G., Capri, G., Rivoltini, L. & de Braud, F., Jun 7 2018, In : Scientific Reports. 8, 1, p. 8703

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Platinum
Neutrophils
Blood Platelets
Lymphocytes
5 Citations (Scopus)

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study

Vernieri, C., Milano, M., Mennitto, A., Maggi, C., Ferrari, B., Rinaldi, L., Mennitto, R., Stefanetti, C., Re, B., Mariani, G., Bianchi, G., Capri, G. & de Braud, F., Sep 1 2017, In : Breast Cancer Research and Treatment. 165, 2, p. 365-373 9 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Retrospective Studies
Disease-Free Survival
Breast Neoplasms